Ipod-O Tablet contains Cefpodoxime Proxetil 200mg and Ofloxacin 200mg, combining a third-generation cephalosporin antibiotic with a fluoroquinolone antibiotic to provide broad-spectrum antibacterial activity. Cefpodoxime Proxetil is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis, leading to cell lysis and death, effective against a wide range of Gram-positive and Gram-negative organisms. Ofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription, thereby exerting bactericidal effects. This combination is indicated for the treatment of mixed infections caused by susceptible strains, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sexually transmitted infections. Ipod-O Tablet should be used according to susceptibility patterns and under medical supervision to minimize the development of resistance. Common adverse effects may include gastrointestinal disturbances, headache, dizziness, and hypersensitivity reactions. Caution is advised in patients with a history of hypersensitivity to cephalosporins or fluoroquinolones, and in those with renal or hepatic impairment. Use during pregnancy and lactation should be avoided unless clearly necessary. Proper dosage and duration should be adhered to as prescribed by a healthcare professional.